Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
Por:
Souissi, A, Patti, F, Spelman, T, Chisari, C, Gargouri, A, John, N, Kermode, AG, Kalincik, T, Butzkueven, H, Sajedi, SA, Lechner-Scott, J, Roos, I, Laureys, G, Taylor, B, Alroughani, R, Khoury, SJ, MacDonell, R, Weinstock-Guttman, B, Havrdova, EK, Maimone, D, Reddel, S, Fabis-Pedrini, M, Willekens, B, Moghadasi, AN, Lalive, P, Lugaresi, A, Ozakbas, S, Solaro, C, Cárdenas-Robledo, S, Shaygannejad, V, Etemadifar, M, Boz, C, Eichau, S, Tomassini, V, Terzi, M, Prat, A, Habek, M, Blanco, Y, Altintas, A, Gerlach, O, Turkoglu, R, Buzzard, K, Skibina, O, Soysal, A, van der Walt, A, Hughes, S, Van Pesch, V, Foschi, M, Surcinelli, A, Prevost, J, Ramo-Tello, C, McGuigan, C, Sa, MJ, Kuhle, J, Spitaleri, D, Singhal, B, Ampapa, R, De Gans, K, Petersen, T, Simu, M, Lapointe, E, Sanchez-Menoyo, JL, Gray, O, Garber, J, Aguera-Morales, E, Gross-Paju, K, Castillo-Triviño, T, Al-Asmi, A, Grigoriadis, N, Inshasi, J, Al-Harbi, T, Hardy, TA, Ramanathan, S, Cambron, M, Shuey, N, Sempere, AP, Csepany, T, Treviño-Frenk, I, Rozsa, C, Cauchi, M, Karabudak, R, Mrabet, S and Gouider, R
Publicada:
4 feb 2026
Resumen:
BackgroundMultiple Sclerosis (MS) severity is influenced by several factors. Understanding the impact of age at disease onset may help to better characterize clinical and disease features across age groups. This study aimed to characterize the clinical features and disability outcomes of late-onset MS (LOMS) and very late-onset MS (vLOMS), compared to adult-onset MS (AOMS).MethodsWe conducted an observational study using data from the MSBase registry and categorized patients based on age at MS onset: AOMS (18-39 years), transition onset (40-49 years), LOMS (50-59 years), and vLOMS (>= 60 years). Disease progression was assessed using the 24 week confirmed disability progression, EDSS4 and 6 milestones, conversion to secondary progressive MS(SPMS), and the first progression independent of relapse activity (PIRA) event. Cox proportional hazard regression models were used to determine unadjusted hazard ratios(HR), and propensity score inverse probability of treatment weighting(PS-IPTW) balanced covariate distributions.ResultsAmong 81,236 patients, 5.2% had LOMS and 1% had vLOMS. Primary progressive MS was more frequent in LOMS and vLOMS (21.7 and 24%, respectively). Patients with LOMS and vLOMS had a significantly increased risk of 24 week confirmed disability progression (HR:LOMS = 1.39, vLOMS = 1.80), EDSS 4 (HR:LOMS = 2.14, vLOMS = 2.95), EDSS 6 (HR:LOMS = 2.33, vLOMS = 6.33), SPMS (HR:LOMS = 1.62, vLOMS = 2.38), and first PIRA event (HR:LOMS = 2.12, vLOMS = 2.93).ConclusionLOMS and vLOMS exhibited a more progressive disease onset and higher disability milestones compared with AOMS.
Filiaciones:
Souissi, A:
Univ Hosp Ctr Razi Mannouba, Neurol Dept, LR18SP03, Tunis, Tunisia
Univ Hosp Ctr Razi Mannouba, Clin Invest Ctr Neurosci & Mental Hlth, Tunis, Tunisia
Tunis El Manar Univ, Fac Med Tunis, Tunis, Tunisia
Patti, F:
Univ Catania, UOS Sclerosi Multipla, Dept Med & Surg & Adv Technol GF Ingrassia, AOU Policlin G Rodolico San Marco, Catania, Italy
Spelman, T:
Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
MSBase Fdn, Melbourne, Vic, Australia
Chisari, C:
Univ Catania, UOS Sclerosi Multipla, Dept Med & Surg & Adv Technol GF Ingrassia, AOU Policlin G Rodolico San Marco, Catania, Italy
Gargouri, A:
Univ Hosp Ctr Razi Mannouba, Neurol Dept, LR18SP03, Tunis, Tunisia
Univ Hosp Ctr Razi Mannouba, Clin Invest Ctr Neurosci & Mental Hlth, Tunis, Tunisia
Tunis El Manar Univ, Fac Med Tunis, Tunis, Tunisia
John, N:
Monash Hlth, Dept Neurol, Clayton, Australia
Kermode, AG:
Univ Western Australia, Sir Charles Gairdner Hosp, Perron Inst Neurol & Translat Sci, QEIIMC, Nedlands, Australia
Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Perth, Australia
Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia
Kalincik, T:
Royal Melbourne Hosp, Neuroimmunol Ctr, Dept Neurol, Melbourne, Australia
Univ Melbourne, Dept Med, CORE, Melbourne, Australia
Butzkueven, H:
Alfred Hosp, Dept Neurol, Melbourne, Australia
Monash Univ, Sch Translat Med, Dept Neurosci, Melbourne, Australia
Sajedi, SA:
Monash Univ, Sch Translat Med, Dept Neurosci, Melbourne, Australia
Golestan Univ Med Sci, Neurosci Res Ctr, Gogan, Iran
Lechner-Scott, J:
Univ Newcastle, Hunter Med Res Inst, Newcastle, Australia
John Hunter Hosp, Hunter New England Hlth, Newcastle, NSW, Australia
Roos, I:
Royal Melbourne Hosp, Neuroimmunol Ctr, Dept Neurol, Melbourne, Australia
Laureys, G:
Univ Hosp Ghent, Dept Neurol, Ghent, Belgium
Taylor, B:
Royal Hobart Hosp, Hobart, Australia
Univ Tasmania, Menzies Inst Med Res, Hobart, Australia
Alroughani, R:
Amiri Hosp, Dept Med, Div Neurol, Sharq, Kuwait
Khoury, SJ:
Amer Univ, Nehme & Therese Tohme Multiple Sclerosis Ctr, Beirut Med Ctr, Beirut, Lebanon
Weinstock-Guttman, B:
Jacobs MS Ctr Treatment & Res, Dept Neurol, New York, NY USA
Havrdova, EK:
Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic
Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic
Gen Univ Hosp, Prague, Czech Republic
Maimone, D:
Azienda Opsed Emergenza Cannizzaro, Ctr Sclerosi Multipla, UOC Neurol, Catania, Italy
Reddel, S:
Concord Repatriat Gen Hosp, Dept Neurol, Sydney, Australia
Fabis-Pedrini, M:
Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Perth, Australia
Univ Western Australia, Perron Inst Neurol & Translat Sci, Perth, Australia
Willekens, B:
Univ Antwerp, Lab Expt Hematol, Fac Med & Hlth Sci,Translat Neurosci Res Grp, Dept Neurol,Vaccine & Infect Inst VAXINFECTIO, Antwerp, Belgium
Moghadasi, AN:
Univ Tehran Med Sci, Neurosci Inst, Multiple Sclerosis Res Ctr, Tehran, Iran
Lalive, P:
Geneva Univ Hosp, Unit Neuroimmunol, Dept Clin Neurosci, Div Neurol, Geneva, Switzerland
Fac Med, Geneva, Switzerland
Lugaresi, A:
Univ Bologna, IRCCS Ist Sci Neurol Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy
Ozakbas, S:
Izmir Univ Econ, Med Point Hosp, Multiple Sclerosis Res Assoc, Izmir, Turkiye
Solaro, C:
Galliera Hosp, Neurol Unit, Genoa, Italy
Cárdenas-Robledo, S:
Hosp Univ Nacl Colombia Bogota, Bogota, Colombia
Univ Nacl Colombia, Fac Med, Ctr Esclerosis Multiple CEMHUN, Dept Neurol,Dept Med Interna, Bogota, Colombia
Shaygannejad, V:
Isfahan Univ Med Sci, Esfahan, Iran
Etemadifar, M:
Isfahan Univ Med Sci, MS Inst, Esfahan, Iran
Isfahan Univ Med Sci, Fac Med, Esfahan, Iran
Boz, C:
Karadeniz Tech Univ, Med Fac, Dept Neurol, Trabzon, Turkiye
Eichau, S:
Hosp Univ Virgen Macarena, Dept Neurol, Seville, Spain
Tomassini, V:
Univ G dAnnunzio, Chieti Pescara, Italy
Annunziata Univ Hosp, Inst Adv Biomed Technol ITAB, MS Ctr, Dept Neurosci Imaging & Clin Sci,Clin Neurol SS, Chieti, Italy
Terzi, M:
Mayis Univ, Med Fac, Samsun, Turkiye
Prat, A:
CHUM, Montreal, PQ, Canada
Univ Montreal, Montreal, PQ, Canada
Habek, M:
Univ Hosp Ctr Zagreb, Dept Neurol, Zagreb, Croatia
Blanco, Y:
Hosp Clin Barcelona, Ctr Neuroimmunol, Serv Neurol, Barcelona, Spain
Altintas, A:
Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkiye
Koc Univ, Koc Univ Res Ctr Translat Med KUTTAM, Sch Med, Istanbul, Turkiye
Gerlach, O:
Acad MS Ctr Zuyd, Zuyderland Med Ctr, Dept Neurol, Heerlen, Netherlands
Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurol, Med Ctr, NL-6131 BK Maastricht, Netherlands
Turkoglu, R:
Haydarpasa Numune Training & Res Hosp, Dept Neurol, Istanbul, Turkiye
Buzzard, K:
Monash Univ, Box Hill Hosp, Eastern Hlth Clin Sch, Dept Neurosci, Box Hill, Box Hill, Australia
Skibina, O:
Box Hill Hosp, Dept Neurol, Box Hill, Australia
Monash Univ, Eastern Hlth Clin Sch, Dept Neurosci, Melbourne, Australia
Soysal, A:
Bakirkoy Educ & Res Hosp Psychiat & Neurol Dis, Istanbul, Turkiye
van der Walt, A:
Alfred Hosp, Dept Neurol, Melbourne, Australia
Monash Univ, Sch Translat Med, Dept Neurosci, Melbourne, Australia
Hughes, S:
Royal Victoria Hosp, Belfast, North Ireland
Van Pesch, V:
Clin Univ St Luc, Dept Neurol, Brussels, Belgium
Catholic Univ Louvain, Neuve, Belgium
Foschi, M:
S Maria Delle Croci Hosp, MS Ctr, Dept Neurosci, Neurol Unit,AUSL Romagna, Ravenna, Italy
Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy
Surcinelli, A:
S Maria Delle Croci Hosp, MS Ctr, Dept Neurosci, Neurol Unit,AUSL Romagna, Ravenna, Italy
Prevost, J:
CSSS St Jerome, St Jerome, PQ, Canada
:
Hosp Germans Trias i Pujol, Dept Neurosci, Badalona, Spain
McGuigan, C:
St Vincents Univ Hosp, Dublin, Ireland
Univ Coll Dublin, Sch Med, Dublin, Ireland
Sa, MJ:
Ctr Hosp Univ Sao Joao, Dept Neurol, Porto, Portugal
UFP, Rede Invest Saude, Inst Invest, FCS ,FP I3ID, Porto, Portugal
Univ Fernando Pessoa, RISE UFP, Inovacao & Desenvolvimento Fernando Pessoa, Porto, Portugal
Kuhle, J:
Univ Hosp, Dept Neurol, Basel, Switzerland
Univ Hosp, Multiple Sclerosis Ctr, Basel, Switzerland
Univ Hosp, Res Ctr Clin Neuroimmunol & Neurosci RC2NB, Dept Biomed, Basel, Switzerland
Univ Hosp, Res Ctr Clin Neuroimmunol & Neurosci RC2NB, Dept Clin Res, Basel, Switzerland
Univ Basel, Basel, Switzerland
Spitaleri, D:
Azienda Osped Rilievo Nazl San Giuseppe Moscati Av, UO Cardiol UTIC, Avellino, Italy
Singhal, B:
Bombay Hosp & Med Res Ctr, Inst Med Sci, Dept Pediat, Mumbai, India
Ampapa, R:
Nemocnice Jihlava, Neurol Oddeleni, Jihlava, Czech Republic
De Gans, K:
Groene Hart Ziekenhuis, Gouda, Netherlands
Petersen, T:
Aarhus Univ Hosp, Aarhus, Denmark
Simu, M:
Univ Med & Pharm Victor Babes Timisoara, Timisoara, Romania
Lapointe, E:
Ctr Hosp Univ Sherbrooke, Div Neurol, Med, Sherbrooke, PQ, Canada
Sanchez-Menoyo, JL:
Usansolo Univ Hosp, Dept Neurol, Osakidetza Basque Hlth Serv, Galdakao, Spain
Biocruces Bizkaia Hlth Res Inst, Galdakao, Spain
Gray, O:
South Eastern HSC Trust, Belfast, North Ireland
Garber, J:
Westmead Hosp, Dept Neurol, Sydney, Australia
Aguera-Morales, E:
Univ Cordoba, Dept Med & Surg, Cordoba, Spain
Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain
Gross-Paju, K:
West Tallinn Cent Hosp, Multiple Sclerosis Ctr, Tallinn, Estonia
Castillo-Triviño, T:
Hosp Univ Donostia, San Sebastian, Spain
IIS Biodonostia, San Sebastian, Spain
Al-Asmi, A:
Sultan Qaboos Univ, Coll Med & Hlth Sci, Al Khoud, Oman
Grigoriadis, N:
Ahepa Univ Hosp, Dept Neurol, Thessaloniki, Greece
Aristotle Univ Thessaloniki, Fac Med, Thessaloniki, Greece
Inshasi, J:
Rashid Hosp, Dubai, U Arab Emirates
Al-Harbi, T:
King Fahad Specialist Hosp Dammam, Neurol Dept, Dammam, Saudi Arabia
Hardy, TA:
Univ Western Australia, Perron Inst Neurol & Translat Sci, Perth, Australia
Ramanathan, S:
Univ Sydney, Sydney, Australia
Univ Sydney, Fac Med & Hlth, Kids Neurosci Ctr, Translat Neuroimmunol Grp, Sydney, Australia
Univ Sydney, Fac Med & Hlth, Brain & Mind Ctr, Sydney, Australia
Concord Hosp, Concord Clin Sch, Dept Neurol, Sydney, Australia
Cambron, M:
Az Sint Jan Brugge, Neurol, Brugge, Belgium
Univ Ghent, Ghent, Belgium
Shuey, N:
Vincents Hosp, Melbourne, Australia
Sempere, AP:
Hosp Gen Univ Alicante, Neurol Unit, Alicante, Spain
Univ Miguel Hernandez, Spain ISABIAL, Alicante, Spain
Csepany, T:
Univ Debrecen, Fac Med, Dept Neurol, Debrecen, Hungary
Treviño-Frenk, I:
Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol, Mexico City, Mexico
Rozsa, C:
Jahn Ferenc Teaching Hosp, Budapest, Hungary
Cauchi, M:
Mater Dei Hosp, Neurosci Dept, Birkirkara, Malta
Karabudak, R:
Yeditepe Univ, Kosuyolu Hosp, Fac Med, Dept Neurol Sci,Clin Neuroimmunol, Istanbul, Turkiye
Yeditepe Univ, Kosuyolu Hosp, MS Unit, Istanbul, Turkiye
Mrabet, S:
Univ Hosp Ctr Razi Mannouba, Neurol Dept, LR18SP03, Tunis, Tunisia
Univ Hosp Ctr Razi Mannouba, Clin Invest Ctr Neurosci & Mental Hlth, Tunis, Tunisia
Tunis El Manar Univ, Fac Med Tunis, Tunis, Tunisia
Gouider, R:
Univ Hosp Ctr Razi Mannouba, Neurol Dept, LR18SP03, Tunis, Tunisia
Univ Hosp Ctr Razi Mannouba, Clin Invest Ctr Neurosci & Mental Hlth, Tunis, Tunisia
Tunis El Manar Univ, Fac Med Tunis, Tunis, Tunisia
Austin Hlth, Melbourne, Australia
Green Submitted
|